Related Experiment Videos
ERPs differ from neurometric tests in assessing HIV-associated cognitive deficit
Jaime L Tartar1, Colleen M Sheehan, Allan J Nash
1Harvard Medical School and VA Boston Healthcare System, Department of Psychiatry, Research 151-C 940 Belmont Street, Brockton, MA 02301, USA. jaime_tartar@hms.harvard.edu
Neuroreport
|July 3, 2004
Summary
This study shows that brain electrical potentials (P3 ERP) and standard tests both track cognitive decline in women with HIV. P3 ERP identified HIV groups, while standard tests showed differences between clinical HIV stages.
Area of Science:
- Neuroscience
- Immunology
- Psychology
Background:
- HIV-associated cognitive deficits have an unclear onset and progression.
- Understanding cognitive changes is crucial for managing HIV central nervous system impairments.
Purpose of the Study:
- To compare physiological (P3 ERP) and neurometric assessments of cognitive decline in HIV-infected women.
- To evaluate the utility of these measures in differentiating cognitive impairment across HIV disease stages.
Main Methods:
- Auditory event-related potentials (P3 ERP) were recorded from adult women.
- Standard neurometric (pencil and paper) tests were administered.
- Participants included HIV-asymptomatic, HIV-symptomatic, and HIV-negative control groups.
Main Results:
- P3 ERP measures distinguished both HIV clinical groups from the HIV-negative control group.
- Neurometric tests were more sensitive in detecting cognitive differences between the HIV-asymptomatic and HIV-symptomatic groups.
- Both assessment types provided valuable, complementary information.
Conclusions:
- P3 ERP and neurometric tests are useful for tracking cognitive decline in HIV.
- These complementary methods aid in diagnosing and treating HIV-associated central nervous system impairments.